Whether patients haven't yet reached their weight loss goals on lower-dose Wegovy injectables, or they simply have a more significant amount of weight to lose, the 21% weight loss demonstrated in the STEP UP trial, if all patients stayed on treatment, shows what's possible with this new dose, and that's an opportunity we're excited to provide," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk
On the other hand, much of the research data so far suggests that amylin drugs dont produce as much weight loss as certain GLP-1s
If you experience these symptoms, consult with your healthcare professional
Deficiency Lipoic acid deficiency has been described in rare cases of inherited mutations in the lipoic acid biosynthetic pathway
Consider switching to high-carb drinks
Understanding these factors can help patients and clinicians develop targeted management strategies to minimize this uncomfortable but generally benign side effect